Webonly the last name of the first author followed by the words et al. (‘et al.’ is Latin for ‘and others’) E.g. (Nye, Melissen, Szondi, Leonard, 2015). E.g. (Nye et al., 2015) Over 6 authors in one work: If a work has six (6) or more authors, cite only the last name of the first author followed by et al. each time you refer to this work. WebIf experimental animals were used in the research, IOVS requires that authors confirm adherence to the ARVO Statement for the Use of Animals in Ophthalmic and Vision …
Author guidelines - IOPscience - Publishing Support
WebIOVS Investigative Ophthalmology & Visual Science Dear Author: Enclosed are page proofs for your manuscript to be published in Investigative Ophthalmology & Visual Science. Review these proofs carefully, as this is your final opportunity to … Web3 jun. 2024 · Author Response: Letter to the Editor of IOVS From Joseph L. Demer and Robert A. Clark Regarding Joel M. Miller, "EOM Pulleys and Sequelae: A Critical Review" Invest Ophthalmol Vis Sci. 2024 Jun 3;61(6):9. doi: 10.1167/iovs.61.6.9. Author Joel M … cryptoassets basics
Investigative Ophthalmology and Visual Science (IOVS)
Web8 okt. 2024 · (In the years leading up to this, IOVS was strictly hybrid in the sense that authors had an option to pay to make their work immediately freely available, but less than 1% did.) This article describes how ARVO journals successfully transitioned to open access and are subsequently thriving. WebIt is the author’s responsibility to ensure that patient anonymity is carefully protected. Authors from U.S. institutions must comply with all regulations of the Health Insurance Portability and Accountability Act (HIPAA) of 1996. Unless authors have written permission from the patient (or, where applicable, the next of kin), WebAuthors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. duragesic absorption